68Ga-DOTATATE PET/CT in Oncogenic Osteomalacia
68Ga-DOTATATE PET/CT for Detection and Evaluation of the Causative Tumor of Oncogenic Osteomalacia
Sponsor: Peking Union Medical College Hospital
A EARLY_PHASE1 clinical study on Mesenchymal Tumor and Oncogenic Osteomalacia, this trial is ongoing. The trial is conducted by Peking Union Medical College Hospital and has accumulated 10 data snapshots since 2011. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Unknown EARLY_PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Unknown EARLY_PHASE1
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status EARLY_PHASE1
-
Aug 2018 — Jan 2021 [monthly]
Unknown Status EARLY_PHASE1
-
Jul 2018 — Aug 2018 [monthly]
Unknown Status EARLY_PHASE1
▶ Show 5 earlier versions
-
Jun 2018 — Jul 2018 [monthly]
Unknown Status EARLY_PHASE1
-
Feb 2018 — Jun 2018 [monthly]
Unknown Status EARLY_PHASE1
Status: Recruiting → Unknown Status
-
May 2017 — Feb 2018 [monthly]
Recruiting EARLY_PHASE1
Status: Unknown Status → Recruiting
-
Feb 2017 — May 2017 [monthly]
Unknown Status EARLY_PHASE1
Phase: Phase 0 → EARLY_PHASE1
-
Jan 2017 — Feb 2017 [monthly]
Unknown Status Phase 0
First recorded
Dec 2011
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Peking Union Medical College Hospital
For direct contact, visit the study record on ClinicalTrials.gov .